The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study
Some of the Americans who need PrEP the most face the greatest barriers to getting it
As PrEP knowledge increases in San Francisco, 12,500 people now thought to be on PrEP
New HIV prevention products will need marketing and effective health services to reach the people who need them
Huge diversity in current HIV vaccine research, Research for Prevention conference hears
New microbicide enema achieves high levels of drug in rectal tissues in monkeys
Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives
Vaginal and rectal bacteria may have a big influence on HIV transmission and microbicide efficacy
Policy makers’ inaction is leading people to take PrEP ‘in the wild’
Anal sex may transmit four in ten HIV infections in US women at high risk
Second case report of PrEP failure due to drug-resistant virus
